Arabic Arabic English English French French German German
dark

Leading Gene Writing Company Tessera Therapeutics Announces Pivotal Expansion of Leadership Team

Tessera Therapeutics announced today the appointment of Howard Liang, Ph.D., as President and Chief Financial Officer . Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Pharma Faces a Turn in the Tides as Biden Demands Health Care Reforms

Next Post

COVID Vaccine’s 2nd Dose Boosts Body Immunity, MOH Says

Related Posts
Total
0
Share